Court of Appeal agrees: breast cancer formulation patents to be revoked

By Kendall-Windless, C., Sharples, A.

On 27 July 2016, the Court of Appeal of England and Wales handed down its judgment in Hospira UK Limited v Genentech, Inc, upholding Birss J’s decision at first instance that the two patents in question were invalid on the grounds of lack of inventive step and added matter.

…read more

Source:: Journal of Intellectual Property Law & Practice